Earnings Summary

Minerva Neurosciences, Inc.’s net profit fell -71028107.62% since last year same period to $-6192036Mn in the Q2 2023. On a quarterly growth basis, Minerva Neurosciences, Inc. has generated 41.42% jump in its net profits since last 3-months.

Minerva Neurosciences, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.01 - a 23.48% jump from last quarter’s estimates.

Minerva Neurosciences, Inc.’s earning per share (EPS) estimates for the current year stand at -1.01.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Minerva Neurosciences, Inc.’s return on assets (ROA) stands at -0.19.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Minerva Neurosciences, Inc.’s return on equity (ROE) stands at -6.75.